The Journal of the Pharmacy Society of Wisconsin
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Editorial Plans
    • Submit a Manuscript
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • About
    • Advertise in The Journal
    • Editorial Advisory Committee
  • Contact

Breaking Barriers with Aducanumab: Examining Alzheimer's Treatments and Implications for Patients

by Zoe E. Green, 2025 PharmD Candidate, Elena M. Hofbauer, 2025 PharmD Candidate, Riley Q. Hall, 2025 PharmD Candidate, Brandon B. Johnson, 2025 PharmD Candidate 

Alzheimer’s disease is a neurodegenerative disorder affecting millions of patients worldwide, yet treatment options remain limited. Foryears, the mainstay of treatment has been cholinesterase inhibitors to increase concentrations of acetylcholine to stabilize cognitive function. Aducanumab (Aduhelm®) is a newly approved medication that targets beta-amyloid plaques, a hallmark of the disease. However, its approval has been surrounded by controversy, ultimately leaving a consensus on the medication’s efficacy in question. Excessive costs and adverse reactions associated with treatment also have significant implications for patients and their caregivers. The purpose of this piece is to review current treatment recommendations for Alzheimer’s disease, focusing on the recently approved monoclonal antibodies.

Keywords: Aducanumab, Antibodies, Monoclonal, Cholinesterase Inhibitors, Amyloid beta-Peptides, Acetylcholine, Caregivers, Plaque, Amyloid, Cholinesterases​

​
Download PDF

2023 May/June Table of Contents 

The Journal of the Pharmacy Society of Wisconsin (ISSN 2837-8229)


Past Issues

2020
2021
​2022
2019
2018
2017

About PSW

www.pswi.org

Contact Us

thejournal@pswi.org
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Editorial Plans
    • Submit a Manuscript
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • About
    • Advertise in The Journal
    • Editorial Advisory Committee
  • Contact